Reacción #4270

ord-301ed65de99248bebe2bd6e6ac674570

Ecuación de reacción

C#CCCC(=O)N1c2ccccc2C(=O)Nc2cccnc21
5,11-dihydro-11-[1-oxo-4-pentynyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
C=O
paraformaldehyde
C1CCNCC1
piperidine
O=C1Nc2cccnc2N(C(=O)CCC#CCN2CCCCC2)c2ccccc21
5,11-Dihydro-11-[1-oxo-6-(1-piperidinyl)-4-hexynyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Temperaturais refluxed for 1 hour
  2. 2
    Filtraciónare filtered off
  3. 3
    Otrothe filtrate is evaporated to dryness in vacuo
  4. 4
    OtroThe crude product is purified by column chromatography on silica gel (mobile phase: ethyl acetate, ethyl acetate+10% methanol)
  5. 5
    OtroAfter recrystallisation from ethyl acetate, 2.7 g (21% of theory) of the desired compound
  6. 6
    Otroare obtained

Procedimiento

A mixture consisting of 9.6 g (0.03 mol) of 5,11-dihydro-11-[1-oxo-4-pentynyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one, 1.08 g (0.036 mol) of paraformaldehyde, 3.06 g (0.036 mol) of piperidine, 0.2 g of copper(I) chloride and 150 ml of dioxan is refluxed for 1 hour. After the reaction has ended the insoluble constituents are filtered off and the filtrate is evaporated to dryness in vacuo. The crude product is purified by column chromatography on silica gel (mobile phase: ethyl acetate, ethyl acetate+10% methanol). After recrystallisation from ethyl acetate, 2.7 g (21% of theory) of the desired compound are obtained, m.p. 197° C.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US04724236uspto-grants-1988_02